Source: EURLEX
Language: en
Format: md

|  |  |  |  |
| --- | --- | --- | --- |
| 20.1.2020 | EN | Official Journal of the European Union | C 19/46 |

---

Judgment of the General Court of 28 November 2019 — August Wolff v EUIPO — Faes Farma (DermoFaes)

(Case T-643/18) [(1)](#ntr1-C_2020019EN.01004602-E0001)

(EU trade mark - Opposition proceedings - Application for EU word mark DermoFaes - Earlier EU word mark Dermowas - Relative ground for refusal - Likelihood of confusion - Article 8(1)(b) of Regulation (EU) 2017/1001)

(2020/C 19/55)

Language of the case: English

Parties

Applicant: Dr. August Wolff GmbH & Co. KG Arzneimittel (Bielefeld, Germany) (represented by: A. Thünken, lawyer)

Defendant: European Union Intellectual Property Office (represented by: J. Ivanauskas and H. O’Neill, acting as Agents)

Other party to the proceedings before the Board of Appeal of EUIPO, intervener before the General Court: Faes Farma, SA (Lamiaco-Leioa, Spain) (represented by: A. Vela Ballesteros and S. Fernandez Malvar, lawyers)

Re:

Action brought against the decision of the Second Board of Appeal of EUIPO of 14 June 2018 (Case R 1842/2017-2) relating to opposition proceedings between Dr. August Wolff and Faes Farma.

Operative part of the judgment

The Court:

|  |  |
| --- | --- |
| 1. | Dismisses the action; |

|  |  |
| --- | --- |
| 2. | Orders Dr. August Wolff GmbH & Co. KG Arzneimittel to bear its own costs and to pay the costs incurred by the European Union Intellectual Property Office (EUIPO) and by Faes Farma, SA, including those necessarily incurred by Faes Farma, SA, before the Board of Appeal of EUIPO. |

---

---

[Top](#document1)